334 related articles for article (PubMed ID: 33186639)
1. Targeting the endocannabinoid system with microbial interventions to improve gut integrity.
Jansma J; Brinkman F; van Hemert S; El Aidy S
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110169. PubMed ID: 33186639
[TBL] [Abstract][Full Text] [Related]
2. Major Depressive Disorder and gut microbiota - Association not causation. A scoping review.
Łoniewski I; Misera A; Skonieczna-Żydecka K; Kaczmarczyk M; Kaźmierczak-Siedlecka K; Misiak B; Marlicz W; Samochowiec J
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110111. PubMed ID: 32976952
[TBL] [Abstract][Full Text] [Related]
3. Endocannabinoids--at the crossroads between the gut microbiota and host metabolism.
Cani PD; Plovier H; Van Hul M; Geurts L; Delzenne NM; Druart C; Everard A
Nat Rev Endocrinol; 2016 Mar; 12(3):133-43. PubMed ID: 26678807
[TBL] [Abstract][Full Text] [Related]
4. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system.
Chen M; Hou P; Zhou M; Ren Q; Wang X; Huang L; Hui S; Yi L; Mi M
Clin Nutr; 2020 Apr; 39(4):1264-1275. PubMed ID: 31189495
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota: An intermediary between metabolic syndrome and cognitive deficits in schizophrenia.
Zeng C; Yang P; Cao T; Gu Y; Li N; Zhang B; Xu P; Liu Y; Luo Z; Cai H
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110097. PubMed ID: 32916223
[TBL] [Abstract][Full Text] [Related]
7. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
Goyal D; Ali SA; Singh RK
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
[TBL] [Abstract][Full Text] [Related]
8. How Microbes Affect Depression: Underlying Mechanisms via the Gut-Brain Axis and the Modulating Role of Probiotics.
Suda K; Matsuda K
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163104
[TBL] [Abstract][Full Text] [Related]
9. Narrative review on potential role of gut microbiota in certain substance addiction.
Qin C; Hu J; Wan Y; Cai M; Wang Z; Peng Z; Liao Y; Li D; Yao P; Liu L; Rong S; Bao W; Xu G; Yang W
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110093. PubMed ID: 32898589
[TBL] [Abstract][Full Text] [Related]
10. Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis.
Person H; Keefer L
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Apr; 107():110209. PubMed ID: 33326819
[TBL] [Abstract][Full Text] [Related]
11. Probiotics for Alzheimer's Disease: A Systematic Review.
Naomi R; Embong H; Othman F; Ghazi HF; Maruthey N; Bahari H
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010895
[TBL] [Abstract][Full Text] [Related]
12. Emerging role of Gut-microbiota-brain axis in depression and therapeutic implication.
Evrensel A; Tarhan KN
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110138. PubMed ID: 33075447
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota, kynurenine pathway and mental disorders - Review.
Więdłocha M; Marcinowicz P; Janoska-Jaździk M; Szulc A
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110145. PubMed ID: 33203568
[TBL] [Abstract][Full Text] [Related]
14. The Microbiota-Gut-Brain Axis in Psychiatric Disorders.
Góralczyk-Bińkowska A; Szmajda-Krygier D; Kozłowska E
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232548
[TBL] [Abstract][Full Text] [Related]
15. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
Amabebe E; Robert FO; Agbalalah T; Orubu ESF
Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota, obesity and diabetes.
Patterson E; Ryan PM; Cryan JF; Dinan TG; Ross RP; Fitzgerald GF; Stanton C
Postgrad Med J; 2016 May; 92(1087):286-300. PubMed ID: 26912499
[TBL] [Abstract][Full Text] [Related]
17. Microbiome and substances of abuse.
Salavrakos M; Leclercq S; De Timary P; Dom G
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 105():110113. PubMed ID: 32971216
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment.
Liang Y; Cui L; Gao J; Zhu M; Zhang Y; Zhang HL
Mol Neurobiol; 2021 Aug; 58(8):3745-3758. PubMed ID: 33825149
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated brain-gut axis in the setting of traumatic brain injury: review of mechanisms and anti-inflammatory pharmacotherapies.
El Baassiri MG; Raouf Z; Badin S; Escobosa A; Sodhi CP; Nasr IW
J Neuroinflammation; 2024 May; 21(1):124. PubMed ID: 38730498
[TBL] [Abstract][Full Text] [Related]
20. Parasite-Derived Excretory-Secretory Products Alleviate Gut Microbiota Dysbiosis and Improve Cognitive Impairment Induced by a High-Fat Diet.
Wu J; Zhu Y; Zhou L; Lu Y; Feng T; Dai M; Liu J; Xu W; Cheng W; Sun F; Liu H; Pan W; Yang X
Front Immunol; 2021; 12():710513. PubMed ID: 34745091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
